Latest news with #CLI
Zawya
19 hours ago
- Business
- Zawya
Ascott Expands Resort Portfolio with Multi-Typology Brand Strategy to Tap on Rising Leisure Travel Demand
11 new signings across high-demand travel markets in Asia and the Middle East bring portfolio to about 50 properties in sought-after resort destinations globally New additions span multiple brands across Phuket (Thailand); Bali and Labuan Bajo (Indonesia); Phu Quoc, Nha Trang, Cam Ranh and Sam Son (Vietnam); Gangneung (South Korea); and Marjan Island, Ras Al Khaimah (UAE) SINGAPORE - Media OutReach Newswire – 11 August 2025 - The Ascott Limited (Ascott), the wholly owned lodging business unit of CapitaLand Investment (CLI), is scaling its global resort footprint through asset-light expansion. Riding on growing demand for experiential stays, Ascott now has around 50 properties in resort destinations in operation and under development worldwide, supported by 11 new signings in the past 10 months secured via management and franchise agreements. These represent about 5% of its global portfolio of over 1,000 properties, reflecting a strategic focus on the fast-growing leisure segment[1]. This momentum is driven by Ascott's multi-typology brand strategy, which adapts well-loved brands such as Ascott, Citadines, lyf, Oakwood, Somerset, The Crest Collection and The Unlimited Collection for resort settings. This approach enables efficient scaling in high-potential destinations while fulfilling lifestyle aspirations of its growing Ascott Star Rewards membership and delivering brand-led solutions that drive long-term value for property owners. Recent signings across Asia and the Middle East reflect Ascott's strategic expansion into key leisure hotspots. These include iconic beach destinations such as Patong Beach in Phuket and Jimbaran Beach in Bali. Ascott is also entering Marjan Island, Ras Al Khaimah's premier man-made coral island known for its pristine beaches. In Vietnam, Ascott is growing its presence in Phu Quoc, voted the world's second-best island[2], and Nha Trang, an established coastal city often dubbed the "Riviera of the South China Sea". The company is also capitalising on emerging opportunities in fast-growing destinations such as Cam Ranh, an up-and-coming aviation and leisure hub, and Sam Son, a rising domestic and regional tourism hotspot. Additionally, Ascott is entering Labuan Bajo, Indonesia — the gateway to Komodo National Park, a UNESCO World Heritage site. In South Korea, it is tapping demand in Gangneung, the leading east coast destination and host of the 2018 Winter Olympics. Ascott's push into resort destinations capitalises on robust industry tailwinds. Global leisure travel spend is projected to triple to US$15 trillion by 2040, fuelled by increasing demand from the burgeoning middle class in emerging markets such as China, India and Saudi Arabia, the rise of experience-led younger travellers, and surging domestic and regional tourism 1. Notably, over 70% of travellers from emerging markets now combine business and leisure trips, highlighting the growing importance of bleisure travel 1. Within this broader trend, the global resort segment – valued at US$300.03 billion in 2023 – is forecast to reach US$945.38 billion by 2030, growing at 18.2% CAGR, driven by rising disposable incomes, increased international travel, and preference for destination-led, experience-rich stays [3]. Ms Serena Lim, Chief Growth Officer, Ascott, said: "As leisure travel continues to outpace global tourism growth[4], we are seeing strong momentum from property owners eager to grow with us in the resort space. Owners are drawn to our flex-hybrid model, which optimises returns and mitigates risk in dynamic leisure markets by serving both short and extended stays within a single operational framework. Complemented by our multi-typology brand strategy, we align the right brand and format to each resort setting, enabling differentiated, locally attuned guest experiences while staying responsive to evolving travel trends. Backed by a loyal and expanding member base seeking elevated leisure experiences, Ascott is well-positioned to deliver long-term value through exceptional resort stays, creating results for owners, delight for guests and impact across the markets we serve." Ms Tan Bee Leng, Chief Commercial Officer, Ascott, said: "Resorts represent a powerful extension of Ascott's brand promise to let guests 'Stay Your Way', unlocking a world of leisure-led experiences that elevate our Ascott Star Rewards (ASR) programme to new heights. From sun-drenched beachfront villas and serene mountain retreats to château stays and immersive wellness escapes, each resort adds lifestyle richness to the loyalty journey, deepening member engagement and incentivising cross-destination travel. At the same time, a growing base of loyal ASR members fuels demand for these differentiated resort offerings globally — accelerating our resort expansion strategy with data-backed insights and a ready community of experience-driven travellers. Ascott's flex-hybrid model and multi-typology brand approach allow us to scale trusted urban brands into resort destinations with local authenticity and operational excellence, creating a virtuous cycle that benefits guests, members and property owners alike." Expanding Reach Across Leisure Hotspots Ascott is expanding into sought-after resort destinations with new property signings that deliver diverse, experiential stays. In Thailand, Ascott Abov Patong Phuket Resort will feature 254 rooms and comprehensive leisure facilities including all-day dining, a swimming pool, rooftop bar, pool bar, spa, gym, kids' club and event spaces. Located just 150 metres from iconic Patong Beach and surrounded by tourist attractions, the resort enjoys a prime position in Thailand's leading leisure destination, known for its strong year-round demand and diverse visitor base. Guided by the brand's understated luxury philosophy, Ascott Abov Patong Phuket Resort will showcase its "Fine Arts Inspired by Nature" concept, blending luxury, tranquility and local artistry in perfect harmony. The project also includes Residences at Ascott Abov Patong Phuket, a 227-unit branded residence, with completion targeted for 2027. Ascott is also scaling its resort portfolio in Vietnam. Somerset Nha Trang, part of the landmark Libera Nha Trang development, will bring the brand's trusted family-friendly resort living to one of Vietnam's most popular beach destinations. Meanwhile, Citadines Selavia Phu Quoc will anchor a mixed-use precinct on the island's popular southwest coast. Opening in 2027, this 369-unit beachfront development will offer premium amenities including a spa with onsen facilities, all-day dining and expansive event spaces. In Cam Ranh, along Long Beach, Ascott will debut the HARRIS brand in Vietnam with the 693-unit HARRIS Resort Cam Ranh. Designed as an all-in-one resort destination, it will feature specialty dining, a beach club, water park and recreational facilities. Business travellers will also be catered for with a ballroom and dedicated meeting spaces. Slated to open in 2026, HARRIS Resort Cam Ranh marks the brand's continued expansion beyond Indonesia into high-potential Southeast Asian markets. Separately, Lasong Hotel & Villas Sam Son by The Unlimited Collection in Thanh Hoa began opening in phases in April 2025, less than six months after signing. The resort offers a distinctive retreat on one of Vietnam's most storied beaches, blending boutique hotel rooms, private villas, wellness amenities – including a Korean jjimjilbang and dedicated spa – a grand ballroom and culturally inspired dining. As the second property under The Unlimited Collection in Vietnam after Anmira Resort & Spa Hoi An by The Unlimited Collection, it underscores Ascott's commitment to culturally immersive experiences in fast-growing leisure destinations. In Indonesia, the 120-key lyf Labuan Bajo marks Ascott's debut in one of the country's most sought-after resort destinations, a rising eco-tourism hub and gateway to UNESCO-listed Komodo National Park. Opening in 2027, the property will introduce lyf's experience-led social living concept to Labuan Bajo, featuring vibrant communal spaces, coworking zones and curated local experiences designed to foster connection and exploration among next-generation travellers. Three other resort developments across Indonesia are also slated to open from 2026 to 2028. In Bali, the 57-unit Oakwood Jimbaran Villas and Residences Bali will provide direct access to the renowned shores of Jimbaran Beach, while the 366-unit Oakwood Premier Berawa Beach Bali will offer upscale beachfront living in the trendsetting district of Canggu. In Sanur, the 180-unit Oakwood Sanur Bali will be positioned within the Special Economic Zone, adjacent to the highly anticipated Bali International Hospital – a future hub for medical tourism. Featuring ocean views and convenient beach access alongside diverse accommodation choices, the property will blend coastal charm with wellness-focused amenities, complemented by recreational facilities, event spaces and destination dining experiences. In South Korea, Ascott is introducing its Oakwood brand to Lagoon Town, a landmark resort complex under development in Gangneung's Cultural Olympic Special Zone. Overlooking both Gyeongpo Lake and Gyeongpo Beach, the 500-key property will meet rising demand for leisure-led extended stays on Korea's scenic east coast. Located just five minutes from Gangneung Station and two hours from Seoul via KTX, the property is positioned to become a key coastal retreat for domestic and international travellers. In the UAE, Al Mahra Resort by The Crest Collection is set to open in 2027 on Marjan Island, Ras Al Khaimah's flagship beachfront leisure destination. The resort will feature 539 uniquely designed rooms and luxury suites with a comprehensive selection of amenities including all-day dining, specialty restaurants, bars, a spa, swimming pool, gym, kids' playroom, club lounge and flexible event spaces – making it a standout destination for upscale coastal getaways. These additions expand Ascott's growing resort portfolio, which includes ski retreat Oakwood Suites Chongli in China's premier winter sports hub, the all-villa Oakwood Ha Long near Vietnam's UNESCO-listed Ha Long Bay, Somerset Pattaya on Thailand's vibrant coast and Château Belmont Tours by The Crest Collection in France's Loire Valley. Ascott will also debut its Preference brand in the Philippines with Balai Dajao by Preference in Siargao island, the country's celebrated surfing capital. The 100-unit property featuring suites and villas is expected to operate from late 2027. With over 20 new properties in resort destinations set to open over the next three years, Ascott continues strengthening its lifestyle hospitality presence in key leisure markets worldwide. Explore Ascott's resort destinations at Hashtag: #Ascott The issuer is solely responsible for the content of this announcement. The Ascott Limited The Ascott Limited (Ascott) is driven by a vision to be the preferred hospitality company, enriching global living with heartfelt experiences. With a portfolio of more than 1,000 properties spanning over 230 cities across more than 40 countries, Ascott's presence spans Asia Pacific, Central Asia, Europe, the Middle East, Africa and the USA. Its diverse collection of award-winning brands includes Ascott, Citadines, lyf, Oakwood, Somerset, The Crest Collection, The Unlimited Collection, Fox, Harris, POP!, Preference, Quest, Vertu and Yello. Ascott specialises in managing and franchising a wide range of lodging options, including serviced residences, hotels, resorts, social living properties and branded residences, catering to the varying needs and preferences of global travellers. Through the Ascott Star Rewards (ASR) loyalty programme, members enjoy exclusive privileges and curated experiences, enhancing every aspect of their travel journey. As a wholly owned business unit of CapitaLand Investment Limited, Ascott generates fee-related earnings by leveraging its expertise in both lodging management and investment management. It also drives the expansion of funds under management by growing its sponsored CapitaLand Ascott Trust and private funds. For more information on Ascott and its sustainability programme, please visit Alternatively, connect with Ascott on Facebook, Instagram, TikTok and LinkedIn. CapitaLand Investment Limited Headquartered and listed in Singapore in 2021, CapitaLand Investment Limited (CLI) is a leading global real asset manager with a strong Asia foothold. As at 31 March 2025, CLI had S$117 billion of funds under management held via stakes in seven listed real estate investment trusts and business trusts and a suite of private real asset vehicles that invest in demographics, disruption and digitalisation-themed strategies. Its diversified real asset classes include retail, office, lodging, industrial, logistics, business parks, wellness, self-storage, data centres, private credit and special opportunities. CLI aims to scale its fund management, lodging management and commercial management businesses globally and maintain effective capital management. As the investment management arm of CapitaLand Group, CLI has access to the development capabilities of and pipeline investment opportunities from CapitaLand Group's development arm. In 2025, CapitaLand Group celebrates 25 years of excellence in real estate and continues to innovate and shape the industry. As a responsible company, CLI places sustainability at the core of what it does and has committed to achieve Net Zero carbon emissions for Scope 1 and 2 by 2050. CLI contributes to the environmental and social well-being of the communities where it operates, as it delivers long-term economic value to its stakeholders. The Ascott Limited
Techday NZ
31-07-2025
- Techday NZ
Tracebit finds major vulnerability in Google Gemini CLI tool
Tracebit has reported the discovery of a vulnerability affecting Google's Gemini CLI, highlighting risks of silent credential theft and unauthorised command execution from untrusted code. The Gemini CLI tool, designed to assist developers in coding with Google Gemini directly from the command line, was released by Google on 25 June. Tracebit identified the vulnerability within two days, describing a combination of improper validation, prompt injection and misleading user experience as enabling the flaw. This allowed potential attackers to execute arbitrary code without the victim's knowledge when inspecting untrusted code, thereby risking the exfiltration of credentials and sensitive data from users' machines to remote servers. Tracebit explained that their blog post reveals a technical method by which an attacker could exploit Gemini CLI. Attackers could achieve silent code execution against users working with untrusted code, and this method might remain hidden from victims due to the exploit's mode of operation. Disclosure and response Tracebit disclosed the vulnerability directly to Google through its Bug Hunters programme. According to a timeline provided by Tracebit, the vulnerability was initially reported to Google's Vulnerability Disclosure Programme (VDP) on 27 June, just two days after Gemini CLI's public release. Upon receipt, Google triaged the vulnerability as a lower priority; however, as the risk became clearer, the classification was upgraded to P1, S1 - the highest priority and most severe status - on 23 July. The Google product team then addressed the vulnerability, releasing an updated version of Gemini CLI (v0.1.14) with a patch on 25 July, followed by an agreed public disclosure on 28 July. During the approximately one-month period between the tool's launch and the deployment of a fix, Tracebit noted that there had been independent discoveries of at least the command validation vulnerability by several other individuals. User impact and mitigation Tracebit has detailed that in the patched version of Gemini CLI, attempts at code injection display the malicious command to users, and require explicit approval for any additional binaries to be executed. This change is intended to prevent the silent execution that the original vulnerability enabled. For users of the CLI, security is now bolstered by making potentially dangerous prompts visible and requiring activation for certain code actions. The update closes the gap that previously allowed attackers to slip malicious commands past unsuspecting developers. "Our security model for the CLI is centered on providing robust, multi-layered sandboxing. We offer integrations with Docker, Podman, and macOS Seatbelt, and even provide pre-built containers that Gemini CLI can use automatically for seamless protection. For any user who chooses not to use sandboxing, we ensure this is highly visible by displaying a persistent warning in red text throughout their session." (Google VDP Team, July 25th) Google's approach to CLI security leverages containerisation and clear warnings for any users opting out of sandboxing, aiming to mitigate the risks involved in running code from untrusted sources. Tracebit's role in the discovery and reporting of the issue also underlines the importance of rapid, independent security research, particularly as AI-powered tools become central to software development workflows. The company continues to focus on equipping security teams to take an 'assume breach' posture in the face of fast-evolving technologies. The vulnerability and its remediation underscore the need for vigilance when examining and running third-party or untrusted code, especially in tools leveraging AI to assist in software development. Users are advised to update to the latest Gemini CLI version and to use sandboxing features when dealing with unknown sources.
Business Wire
28-07-2025
- Business
- Business Wire
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first patient in the Randomized Study of the A uryon Atherecto m y System Used in Combination with Standard B alloon Ang i oplasty Versus S t andard Balloon Angioplasty Alone Treating I nfrapopliteal Lesi on s in Subjects with Critical Limb Ischemia B elow- t he- K nee (AMBITION BTK). AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon angioplasty alone, in treating infrapopliteal lesions in patients with Critical Limb Ischemia (CLI). The primary endpoint will be evaluated using a win-ratio approach, comparing the two treatment groups based on the following components in a hierarchical manner at 12 months: freedom from major amputation, freedom from clinically driven target lesion revascularization (CD-TLR), and primary patency. The RCT will include up to 224 patients at up to 30 sites. In parallel, a companion registry will enroll up to 1,500 additional patients who are ineligible for the RCT and are treated with the Auryon System above or below the knee. 'The enrollment of the first patient in the AMBITION BTK trial is a significant milestone in our commitment to advancing clinical evidence for the treatment of below-the-knee peripheral artery disease (PAD),' said Laura Piccinini, Senior Vice President/General Manager, Cardiovascular & International, AngioDynamics. 'There is a pressing need for new treatment strategies to help patients suffering from chronic limb ischemia, and we are proud to partner with clinicians to evaluate the Auryon System in this important setting.' The overall risk of limb loss in CLI is estimated at 20–25% at one year if left untreated, reflecting a large impact on quality of life and healthcare costs. 1 Incidence of infrapopliteal disease in patients with CLI, particularly in the diabetic population, is estimated to be >70%. 2 'Treatment options for below-the-knee lesions are still limited and often depend heavily on balloon angioplasty,' said AMBITION BTK Co-Principal Investigator Ehrin Armstrong, FACC, FSCAI, FSVM, MD, MSc, Interventional Cardiologist and Vascular Disease, Director of Clinical Research, Advanced Heart and Vein Center. 'The Auryon laser can restore laminar flow and therefore has the potential to improve outcomes in this challenging patient population significantly.' The first patient in the trial was treated by Anahita Dua, MD, MS, MBA, FACS, a vascular surgeon at Massachusetts General Hospital and associate professor of Surgery at Harvard Medical School, and Co-Principal Investigator of AMBITION BTK. 'I'm excited to perform the first patient case in the AMBITION BTK study. Patients with below-the-knee disease often face limited treatment options and poor long-term outcomes,' said Dr. Dua. 'Across the world, there has been a significant increase in patients with below-the-knee (BTK) disease, which is, unfortunately, resulting in an amputation epidemic. Having new tools and techniques to restore blood flow to the foot, allowing wounds to heal, and patients to preserve both their limbs and lives, is critically important and the focus of this trial. This trial will allow us to collect high-quality, real-world data using a robust research design, helping us truly evaluate the impact of laser technology in BTK disease.' The Auryon laser can be used to treat all infrainguinal lesion types, including above-the-knee (ATK), BTK, and In-Stent Restenosis (ISR) 3,4,5,6 and, to date, it has been used to treat more than 100,000 patients in the United States and worldwide. 7 Visit and for more information about the AMBITION BTK RCT and Registry. For important risk information, visit About the Auryon Atherectomy System The Auryon Atherectomy System uses innovative technology to deliver powerful treatment of arterial occlusions. The Auryon Atherectomy System is the first laser atherectomy system to efficiently treat any lesion type, any lesion length, at any lesion location, with minimal impact on vessel walls. 3,5,8,9 The Auryon Atherectomy System uses solid-state laser technology for the treatment of PAD and is FDA cleared with an indication for treatment, including atherectomy, of infrainguinal stenoses and occlusions, including ISR. 4,6 The Auryon System's targeted biological reactions minimize the risk of perforation and preserve the ability to vaporize lesions without thermal ablation. 3,5,8,9 The Auryon System uses a 355nm wavelength laser platform which enables the use of longer wavelengths and shorter pulses to produce a groundbreaking delivery of short UV laser pulses. 4 For more information, please visit About AngioDynamics, Inc. AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life. The Company's innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit Safe Harbor This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics' expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include the words such as 'expects,' 'reaffirms,' 'intends,' 'anticipates,' 'plans,' 'believes,' 'seeks,' 'estimates,' 'projects,' 'optimistic,' or variations of such words and similar expressions, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Investors are cautioned that actual events or results may differ materially from AngioDynamics' expectations, expressed or implied. Factors that may affect the actual results achieved by AngioDynamics include, without limitation, the scale and scope of the COVID-19 global pandemic, the ability of AngioDynamics to develop its existing and new products, technological advances and patents attained by competitors, infringement of AngioDynamics' technology or assertions that AngioDynamics' technology infringes the technology of third parties, the ability of AngioDynamics to effectively compete against competitors that have substantially greater resources, future actions by the FDA or other regulatory agencies, domestic and foreign healthcare reforms and government regulations, results of pending or future clinical trials, overall economic conditions (including inflation, tariffs, labor shortages and supply chain challenges including the cost and availability of raw materials), the results of on-going litigation, challenges with respect to third-party distributors or joint venture partners or collaborators, the results of sales efforts, the effects of product recalls and product liability claims, changes in key personnel, the ability of AngioDynamics to execute on strategic initiatives, the effects of economic, credit and capital market conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from group purchasing organizations and competition, the ability of AngioDynamics to obtain regulatory clearances or approval of its products, or to integrate acquired businesses, as well as the risk factors listed from time to time in AngioDynamics' SEC filings, including but not limited to its Annual Report on Form 10-K for the year ended May 31, 2025. AngioDynamics does not assume any obligation to publicly update or revise any forward-looking statements for any reason. AngioDynamics, the AngioDynamics logo and Auryon are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or subsidiary. All other trademarks are property of their respective owners. 1 2 3 Rundback J, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-LaserTM IDE study. Catheter Cardiovasc Interv. 2019;1-8. 4 Auryon System Indications for Use 5 Shammas NW, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Acute and 30-day safety and effectiveness evaluation of Eximo Medical's B-LaserTM, a novel atherectomy device, in subjects affected with infrainguinal peripheral arterial disease: Results of the EXPAD-03 trial. Cardiovas Revasc Med. 2020;21(1):86-92 6 Built-in aspiration available only with the 2.0- and 2.35-mm catheters. 7 AngioDynamics' J.P. Morgan Healthcare Conference Presentation Published 2025. 8 Herzog A, Bogdan S, Glikson M, Ishaaya AA, Love C. Selective tissue ablation using laser radiation at 355 nm in lead extraction by a hybrid catheter; a preliminary report. Lasers Surg Med. 2016;48(3):281-287 9 Vogel A, Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chem Rev. 2003;103(2):577-644 Expand
Business Times
22-07-2025
- Business
- Business Times
Stocks to watch: Singtel, CapitaLand Investment, GHY Culture, Dasin Retail Trust
[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Tuesday (Jul 22): Singtel : Its wholly owned subsidiary Singtel Optus on Monday priced S$160 million in fixed-rate notes due Jul 25, 2035, at 2.726 per cent. The notes, guaranteed by Optus and certain subsidiaries, will be issued on Jul 25 under Optus Finance's three billion euro (S$4.5 billion) medium-term note programme. Singtel shares closed 0.5 per cent or S$0.02 lower at S$4.15, before the announcement. CapitaLand Investment (CLI) : Its subsidiary, Bursa Malaysia-listed CapitaLand Malaysia Trust, posted a distribution per unit of 1.18 sen for the second quarter ended Jun 30, 2025, up 0.9 per cent from the year-ago period. This came as it saw positive rental reversions and income contribution from a logistics property, its manager said in a Monday evening bourse filing. CLI shares ended Monday 0.7 per cent or S$0.02 higher at S$2.77. GHY Culture & Media : The company on Monday announced its tie-up with leading Chinese online entertainment service provider iQiyi to produce two short-form dramas. The collaboration aligns with GHY's business strategies and growth plans to create more monetisation opportunities, said the company, adding that it will further diversify its portfolio of entertainment products and distribution channels. The counter closed flat at S$0.161, before the announcement. Dasin Retail Trust : Trading in its units has been suspended on the Singapore Exchange as the business trust is unable to comply with listing rules requiring the timely release of its financial results and the holding of annual general meetings, said the trustee-manager on Monday. This comes as the management team of Dasin Retail Trust's China units has stopped providing key financial documents required for the preparation of the group's annual financial statements since the third quarter of 2023. Units of Dasin Retail Trust closed flat at S$0.02, after the announcement. Trading halt: Aoxin Q&M Dental called for a trading halt on Tuesday morning pending the release of an announcement. The counter closed on Monday 8 per cent or S$0.004 lower at S$0.046.
Korea Herald
13-07-2025
- Business
- Korea Herald
OECD leading index for S. Korea rises for 7th month in June
A leading economic index for South Korea rose for the seventh consecutive month in June, reaching its highest level in three years and seven months, data showed Sunday, amid easing political uncertainty and expectations for government stimulus. The composite leading indicator of economic activity for South Korea came to 101.08 for June, up from 100.97 a month earlier, according to the data from the Organization for Economic Cooperation and Development. It marked the highest reading since November 2021, when the index stood at 101.09. The figure has been on an upward trend since December last year, following a four-month decline from August. The CLI gauges how an economy will fare six to nine months ahead, based on industrial output, gross domestic product, and housing and financial market conditions. South Korea's CLI ranked second among OECD countries in June, trailing only Britain. It has held the No. 2 spot since March. The figure also surpassed the average CLI readings for the Group of 20 (100.50) and the Group of Seven (100.51) nations. Experts said the higher index reflects South Korea's stronger economic recovery outlook compared to other major economies, supported by easing political tensions and the government's aggressive fiscal measures. The Lee Jae Myung administration, which took office on June 4 after the impeachment of former President Yoon Suk Yeol, has pledged to boost weak domestic demand. As part of this effort, the government proposed a 31.8 trillion-won ($23.3 billion) supplementary budget, including universal cash handouts. In response, the Bank of Korea consumer sentiment in June rose to its highest level in four years, while the stock market surged to a near four-year high on Thursday. However, some analysts warned that external risks remain. Ongoing trade tensions with the United States, highlighted by Washington's 25 percent reciprocal tariffs on Korean imports, pose a potential headwind for Asia's fourth-largest economy. "Short-term expectations are positive thanks to fiscal expansion, low interest rates and a stabilizing exchange rate," said professor Kim Jung-sik from Yonsei University. "But over the medium to long term, challenges such as weakening industrial competitiveness, a shrinking labor market, US trade policy uncertainty and slowing global demand could weigh on growth." (Yonhap)
